The 2018 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

A West Coast footprint and professional focus: Evoke's CEO on its Giant acquisition

Reid Connolly talks the benefits of buying San Francisco-based firm Giant.

MM&M kicks off contest to find best places to work in healthcare marketing

Being named among the MM&M Best Places to Work can help you stand out in the race for talent. Here's how the contest works.

CCO firings a sign of agencies' waning tolerance for misbehavior

Men in high advertising posts are still misbehaving, but agencies are taking the behavior more seriously now, and acting swiftly to address it.

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Celgene's drug will now have time to establish itself in the market without generic competition.

Stelara highlights J&J's Q2 performance

Stelara highlights J&J's Q2 performance

The company posted a sales increase of 10.6% in the second quarter.

Publicis Health acquires Payer Sciences

Publicis Health acquires Payer Sciences

Payer Sciences is a health marketing agency that uses data and analytics to gather insights about payer behavior.

Five things for pharma marketers to know: Friday, July 20, 2018

Five things for pharma marketers to know: Friday, July 20, 2018

More drugmakers vow to halt price increases; FDA considers allowing imported drugs in some cases; Trump administration examines rebates.

Healthcare takes blame for disappointing Q2 for Publicis Groupe

Healthcare takes blame for disappointing Q2 for Publicis Groupe

The holding company has launched a review of its Publicis Health Solutions business after a volatile Q2.

Five things for pharma marketers to know: Thursday, July 19, 2018

Five things for pharma marketers to know: Thursday, July 19, 2018

Healthcare decline weighs on Publicis Q2 earnings; Gottlieb releases biosimilar plan; Roche's lung cancer treatment shows positive results.

Five things for pharma marketers to know: Wednesday, July 18, 2018

Five things for pharma marketers to know: Wednesday, July 18, 2018

Novartis voluntarily halts price increases; Shkreli's former company considers name change; FDA issues guidance to modernize electronic health data in trials.

Study: Healthcare isn't as consumer centric as it wants to be

Study: Healthcare isn't as consumer centric as it wants to be

Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.

Omnicom healthcare revenue up 4.8% in Q2

Omnicom healthcare revenue up 4.8% in Q2

The holding company's overall revenue was up 1.8% in the period to $3.9 billion.

Five things for pharma marketers to know: Tuesday, July 17, 2018

Five things for pharma marketers to know: Tuesday, July 17, 2018

J&J beats expectations on Q2 earnings; AbbVie, Mylan sign U.S. license deal for Humira; Roche's new flu drug meets endpoints.

Huntsworth buys U.S. health shop Giant Creative Strategy for $72m

Huntsworth buys U.S. health shop Giant Creative Strategy for $72m

Huntsworth has continued its expansion by taking a majority stake in U.S. independent healthcare marketing agency Giant Creative Strategy for an initial sum of $72.2m.

Ketchum launches Vital Health, analytics-driven services for healthcare clients

Ketchum launches Vital Health, analytics-driven services for healthcare clients

Vital Health is driven by Ketchum's new analytics tool, Vital Diagnostics.

SapientRazorfish lays off staff amid rumors the brand will be eliminated

SapientRazorfish lays off staff amid rumors the brand will be eliminated

The Publicis-owned agency has laid off around 100 people in the U.S. alone this week